PATENT CLAIM ANALYSIS

Application Number: 16452457
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "008300"]

Abstract:
The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.

Claim (Index 18):
A method of promoting cutaneous wound healing in a subject that has diabetes, the method comprising the step of administering at a wound site on said subject a composition comprising an isolated glial cell derived growth factor (GDNF), or a biologically active fragment thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 100.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14775386', '11648208', '10305667', '10502115', '15538384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6982526899454203
- 35 USC 102 Novelty (BERT): 0.5748980023461783
- Combined Prediction Score: 0.6859172211854961
- Mean Citation Score: 314.07414200000005
- Max Citation Score: 498.97815
- Similarity Product: 342.4572894781709

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test